Products for Research Use Only
RegisterLogin

Rimonabant

CAT: 0804-HY-14136-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-14136-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Rimonabant (SR141716) is a highly potent, brain penetrated and selective central cannabinoid receptor (CB1) antagonist with a Ki of 1.8 nM. Rimonabant (SR141716) also inhibits Mycobacterial membrane protein Large 3 (MMPL3) .
CAS Number
168273-06-1
Product Name Alternative
SR141716
UNSPSC
12352005
Hazard Statement
H301, H319
Target
Bacterial; Cannabinoid Receptor
Type
Reference compound
Related Pathways
Anti-infection; GPCR/G Protein; Neuronal Signaling
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Infection; Metabolic Disease; Cancer
Assay Protocol
https://www.medchemexpress.com/Rimonabant.html
Purity
99.52
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
ClC1=CC=C(C=C1)C2=C(C(C(NN3CCCCC3)=O)=NN2C4=CC=C(C=C4Cl)Cl)C
Molecular Formula
C22H21Cl3N4O
Molecular Weight
463.79
Precautions
H301, H319
References & Citations
[1]Seely KA, Brents LK, Franks LN, Rajasekaran M, Zimmerman SM, Fantegrossi WE, Prather PL. AM-251 and rimonabant act as direct antagonists at mu-opioid receptors: Implications for opioid/cannabinoid interaction studies. Neuropharmacology. 2012 Oct;63 (5) :905-15.|[2]Zhang B, et al. Crystal Structures of Membrane Transporter MmpL3, an Anti-TB Drug Target. Cell. 2019 Jan 24;176 (3) :636-648.e13.|[3]Erdozain, A. M. et al. The inverse agonist effect of rimonabant on G protein activation is not mediated by the cannabinoid CB1 receptor: Evidence from postmortem human brain Biochemical Pharmacology (2012), 83 (2), 260-268.|[4]Leite, C.E., et al. Rimonabant: An antagonist drug of the endocannabinoid system for the treatment of obesity. Pharmacol Rep 61 217-224 (2009) .
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
Launched
Isoform
CB1
Citation 01
Anal Chem. 2025 Jun 3;97 (21) :11099-11109.|Autophagy. 2021 Nov;17 (11) :3592-3606.|Cell. 2019 Jan 24;176 (3) :636-648.e13. |Int J Mol Sci. 2024 May 3;25 (9) :5012.|J Gerontol A Biol Sci Med Sci. 2025 Aug 28:glaf189.|J Psychopharmacol. 2025 Jul 31:2698811251355603.|Structure. 2022 Oct 6;30 (10) :1395-1402.e4.|Cancers (Basel) . 2021 Jan 18;13 (2) :330.|Int J Mol Sci. 2025 Jul 3;26 (13) :6409.|Molecules. 2025 Aug 28;30 (17) :3517.|Neuroscience. 2019 Apr 15:404:246-258.

Alternative Products

CatalogName
MBS3602569-01Rimonabant
A3766-1000Rimonabant hydrochloride
GX9120-10mgRimonabant base
S3021-01Rimonabant (SR141716)

Popular Products